Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study: Complications from childhood ALL and its treatment are common, but can be managed

Publish date:: October 15, 2020

Key clinical point: Childhood ALL can cause acute complications affecting various systems.

Major finding: Infection was the most common complication (88.5%), followed by gastrointestinal (27.6%), and neurologic (26.6%).

Study details: Retrospective analysis of complications in 110 children with ALL treated with the Children’s Oncology Group protocol.

Disclosures: The authors reported that they had no conflicts of interest.

Citation:

Öztürk AP et al. Clin Lymphoma Myeloma Leuk. 2020 Sep 17. doi: 10.1016/j.clml.2020.08.025.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in ALL

In high-risk first relapse ALL, blinatumomab seen superior to consolidation chemo,

Well tolerated with promising responses in ALL/LL: Venetoclax plus navitoclax plus chemotherapy,

Highly effective in Ph-negative B-cell ALL: Hyper-CVAD with sequential blinatumomab,

COVID-19–related outcomes poor for patients with hematologic disease in ASH registry,

Study: Complications from childhood ALL and its treatment are common, but can be managed,